{"transactions":[{"id":4615693,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units - 4","published_at":"2026-09-11T18:13:39.000Z","date":"2026-09-09","kind":"grant","planned":false,"acquired":true,"shares":2423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs that vest on September 9, 2027"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":2423,"derivative":{"underlying":"Common Stock","underlying_shares":2423},"source":{"system":"sec-edgar","filing":"0000724004-26-000097","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000072400426000097/primary_doc.xml","form_type":"4"}},{"id":686287,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units - 3","published_at":"2026-08-17T23:40:52.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":false,"shares":2784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs that vested on August 15, 2026"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2784},"source":{"system":"sec-edgar","filing":"0000724004-26-000091","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/724004/000072400426000091/primary_doc.xml","form_type":"4"}},{"id":686286,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-17T23:40:52.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":true,"shares":2784,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6213,"source":{"system":"sec-edgar","filing":"0000724004-26-000091","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000072400426000091/primary_doc.xml","form_type":"4"}},{"id":709618,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-14T22:41:21.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":3037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the grant date; provided, however, that the stock options shall be fully vested on the earlier of the first anniversary of the grant date or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":3037,"derivative":{"exercise_price":1.97,"expiration_date":"2036-07-10","underlying":"Class A Common Stock","underlying_shares":3037},"source":{"system":"sec-edgar","filing":"0001352413-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000135241326000004/ownership.xml","form_type":"4"}},{"id":709617,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-14T22:41:21.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":62766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of stock options granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over three years as follows: 1/36 of the original grant amount vests in monthly installments for three years following the grant date, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":62766,"derivative":{"exercise_price":1.97,"expiration_date":"2036-07-10","underlying":"Class A Common Stock","underlying_shares":62766},"source":{"system":"sec-edgar","filing":"0001352413-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000135241326000004/ownership.xml","form_type":"4"}},{"id":709616,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-14T22:41:21.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":1975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each share is represented by an additional RSU granted by the Board of Directors. These RSUs vest on the earlier of July 10, 2027 or the date of the issuer's next Annual Meeting of Stockholders, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":44379,"source":{"system":"sec-edgar","filing":"0001352413-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000135241326000004/ownership.xml","form_type":"4"}},{"id":709615,"issuer":{"id":304,"kind":"organization","name":"SERA PROGNOSTICS, INC.","symbol":"SERA"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-14T22:41:21.000Z","date":"2026-07-10","kind":"grant","planned":false,"acquired":true,"shares":42404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\") granted pursuant to the issuer's Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These RSUs vest in three annual installments beginning with July 10, 2027, subject to the Reporting Person continuing to provide services to the issuer."}],"balance_after":42404,"source":{"system":"sec-edgar","filing":"0001352413-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000135241326000004/ownership.xml","form_type":"4"}},{"id":852511,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-10T19:46:59.000Z","date":"2026-03-10","kind":"purchase","planned":false,"acquired":true,"shares":1301,"price":76.35,"value":99331.35,"ownership":{"direct":true},"balance_after":3429,"source":{"system":"sec-edgar","filing":"0000724004-26-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000072400426000022/primary_doc.xml","form_type":"4"}},{"id":1064702,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units - 3","published_at":"2025-08-18T17:45:19.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":2784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive on share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs that vest on August 15, 2026"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":2784,"derivative":{"underlying":"Common Stock","underlying_shares":2784},"source":{"system":"sec-edgar","filing":"0001197710-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/724004/000119771025000004/primary_doc.xml","form_type":"4"}},{"id":1064701,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units - 2","published_at":"2025-08-18T17:45:19.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":false,"shares":1404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive on share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs that vested on August 15, 2025"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1404},"source":{"system":"sec-edgar","filing":"0001197710-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/724004/000119771025000004/primary_doc.xml","form_type":"4"}},{"id":1064700,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-18T17:45:19.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":true,"shares":1404,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2128,"source":{"system":"sec-edgar","filing":"0001197710-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000119771025000004/primary_doc.xml","form_type":"4"}},{"id":1430469,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units - 2","published_at":"2024-08-19T15:08:47.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":1404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs that vest on August 15, 2025"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":1404,"derivative":{"underlying":"Common Stock","underlying_shares":1404},"source":{"system":"sec-edgar","filing":"0001228924-24-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/724004/000122892424000014/primary_doc.xml","form_type":"4"}},{"id":1430468,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units - 1","published_at":"2024-08-19T15:08:47.000Z","date":"2024-08-15","kind":"exercise","planned":false,"acquired":false,"shares":724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs that vest on August 15, 2024"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":724},"source":{"system":"sec-edgar","filing":"0001228924-24-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/724004/000122892424000014/primary_doc.xml","form_type":"4"}},{"id":1430467,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T15:08:47.000Z","date":"2024-08-15","kind":"exercise","planned":false,"acquired":true,"shares":724,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":724,"source":{"system":"sec-edgar","filing":"0001228924-24-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000122892424000014/primary_doc.xml","form_type":"4"}},{"id":1640032,"issuer":{"id":5221,"kind":"organization","name":"MESA LABORATORIES INC /CO/","symbol":"MLAB"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units -1","published_at":"2024-02-16T18:10:10.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs that vest on August 15, 2024"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":724,"derivative":{"underlying":"Common Stock","underlying_shares":724},"source":{"system":"sec-edgar","filing":"0001228924-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/724004/000122892424000002/primary_doc.xml","form_type":"4"}},{"id":1866473,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:22:10.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":35714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service.  The shares underlying any vested restricted stock units shall be released to the reporting person on June 1, 2024."}],"balance_after":82054,"source":{"system":"sec-edgar","filing":"0001209191-23-034585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000120919123034585/doc4.xml","form_type":"4"}},{"id":2204457,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-21T00:12:48.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":19860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in one installment on May 26, 2023."}],"balance_after":46340,"source":{"system":"sec-edgar","filing":"0001209191-22-042798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000120919122042798/doc4.xml","form_type":"4"}},{"id":2204456,"issuer":{"id":89998,"kind":"organization","name":"DermTech, Inc.","symbol":"DMTK"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-21T00:12:48.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":26480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in three equal annual installments over the three-year period following the grant date, subject to the reporting person's continued service."}],"balance_after":26480,"source":{"system":"sec-edgar","filing":"0001209191-22-042798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352413/000120919122042798/doc4.xml","form_type":"4"}},{"id":3403663,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-10-01T22:20:20.000Z","date":"2019-09-30","kind":"disposition_to_issuer","acquired":false,"shares":18295,"price":28.63,"value":523785.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":522216,"source":{"system":"sec-edgar","filing":"0001352413-19-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000006/edgardoc.xml","form_type":"4"}},{"id":3403662,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-10-01T22:20:20.000Z","date":"2019-09-30","kind":"disposition_to_issuer","acquired":false,"shares":8727,"price":28.63,"value":249854.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":540511,"source":{"system":"sec-edgar","filing":"0001352413-19-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000006/edgardoc.xml","form_type":"4"}},{"id":3406044,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-09-26T21:15:59.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":18295,"price":29.93,"value":547569.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":549238,"source":{"system":"sec-edgar","filing":"0001352413-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000004/edgardoc.xml","form_type":"4"}},{"id":3406043,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-09-26T21:15:59.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":15800,"price":29.93,"value":472894.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":567533,"source":{"system":"sec-edgar","filing":"0001352413-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000004/edgardoc.xml","form_type":"4"}},{"id":3406042,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-09-26T21:15:59.000Z","date":"2019-09-25","kind":"grant","acquired":true,"shares":142500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan.  Performance stock units initially granted on September 19, 2018, subject to accomplishment of pre-determined financial performance requirements.  On September 25, 2019, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements.  Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022."}],"balance_after":583333,"source":{"system":"sec-edgar","filing":"0001352413-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000004/edgardoc.xml","form_type":"4"}},{"id":3449978,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":58138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25%  annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations."}],"balance_after":0,"derivative":{"exercise_price":30.34,"expiration_date":"2019-09-15","underlying":"Common Stock","underlying_shares":58138},"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449977,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":70672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25%  annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations."}],"balance_after":0,"derivative":{"exercise_price":23.11,"expiration_date":"2020-03-03","underlying":"Common Stock","underlying_shares":70672},"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449976,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":3862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25%  annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations."}],"balance_after":0,"derivative":{"exercise_price":30.34,"expiration_date":"2019-09-15","underlying":"Common Stock","underlying_shares":3862},"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449975,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":false,"shares":4328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25%  annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations."}],"balance_after":0,"derivative":{"exercise_price":23.11,"expiration_date":"2020-03-03","underlying":"Common Stock","underlying_shares":4328},"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449974,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":3862,"price":44,"value":169928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":440833,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449973,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":3862,"price":30.34,"value":117173.08,"ownership":{"direct":true},"balance_after":444695,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449972,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":58138,"price":44,"value":2558072.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":440833,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449971,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":58138,"price":30.34,"value":1763906.92,"ownership":{"direct":true},"balance_after":498971,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449970,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":4328,"price":44,"value":190432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":440833,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449969,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":4328,"price":23.11,"value":100020.08,"ownership":{"direct":true},"balance_after":445161,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449968,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":70672,"price":44,"value":3109568.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":440833,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3449967,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2019-08-02T21:45:49.000Z","date":"2019-08-01","kind":"exercise","acquired":true,"shares":70672,"price":23.11,"value":1633229.92,"ownership":{"direct":true},"balance_after":511505,"source":{"system":"sec-edgar","filing":"0001352413-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241319000002/edgardoc.xml","form_type":"4"}},{"id":3803003,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-10-02T12:45:28.000Z","date":"2018-09-30","kind":"disposition_to_issuer","acquired":false,"shares":8727,"price":46,"value":401442.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":440833,"source":{"system":"sec-edgar","filing":"0001352413-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000012/edgardoc.xml","form_type":"4"}},{"id":3803002,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-10-02T12:45:28.000Z","date":"2018-09-30","kind":"disposition_to_issuer","acquired":false,"shares":18295,"price":46,"value":841570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":449560,"source":{"system":"sec-edgar","filing":"0001352413-18-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000012/edgardoc.xml","form_type":"4"}},{"id":3807851,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-09-26T18:55:15.000Z","date":"2018-09-25","kind":"disposition_to_issuer","acquired":false,"shares":18295,"price":46.65,"value":853461.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":467855,"source":{"system":"sec-edgar","filing":"0001352413-18-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000010/edgardoc.xml","form_type":"4"}},{"id":3810147,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-09-21T16:02:38.000Z","date":"2018-09-19","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan.  Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements.  On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements.  Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021."}],"balance_after":486150,"source":{"system":"sec-edgar","filing":"0001352413-18-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000008/edgardoc.xml","form_type":"4"}},{"id":3813531,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-09-18T20:15:45.000Z","date":"2018-09-17","kind":"disposition_to_issuer","acquired":false,"shares":11025,"price":46.35,"value":511008.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":321150,"source":{"system":"sec-edgar","filing":"0001352413-18-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000006/edgardoc.xml","form_type":"4"}},{"id":3868188,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-13T20:16:46.000Z","date":"2018-07-11","kind":"exercise","acquired":false,"shares":77654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":30.12,"exercise_date":"2013-02-18","expiration_date":"2019-02-18","underlying":"Common Stock","underlying_shares":77654},"source":{"system":"sec-edgar","filing":"0001352413-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000004/edgardoc.xml","form_type":"4"}},{"id":3868187,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-07-13T20:16:46.000Z","date":"2018-07-11","kind":"exercise","acquired":false,"shares":2346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":30.12,"exercise_date":"2013-02-18","expiration_date":"2019-02-18","underlying":"Common Stock","underlying_shares":2346},"source":{"system":"sec-edgar","filing":"0001352413-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000004/edgardoc.xml","form_type":"4"}},{"id":3868186,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-07-13T20:16:46.000Z","date":"2018-07-11","kind":"sale","acquired":false,"shares":2346,"price":41,"value":96186.0,"ownership":{"direct":true},"balance_after":332175,"source":{"system":"sec-edgar","filing":"0001352413-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000004/edgardoc.xml","form_type":"4"}},{"id":3868185,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-07-13T20:16:46.000Z","date":"2018-07-11","kind":"exercise","acquired":true,"shares":2346,"price":30.12,"value":70661.52,"ownership":{"direct":true},"balance_after":334521,"source":{"system":"sec-edgar","filing":"0001352413-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000004/edgardoc.xml","form_type":"4"}},{"id":3868184,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-07-13T20:16:46.000Z","date":"2018-07-11","kind":"sale","acquired":false,"shares":77654,"price":41,"value":3183814.0,"ownership":{"direct":true},"balance_after":332175,"source":{"system":"sec-edgar","filing":"0001352413-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000004/edgardoc.xml","form_type":"4"}},{"id":3868183,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-07-13T20:16:46.000Z","date":"2018-07-11","kind":"exercise","acquired":true,"shares":77654,"price":30.12,"value":2338938.48,"ownership":{"direct":true},"balance_after":409829,"source":{"system":"sec-edgar","filing":"0001352413-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241318000004/edgardoc.xml","form_type":"4"}},{"id":3911539,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-01T21:43:57.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":22.93,"exercise_date":"2018-05-30","expiration_date":"2018-09-10","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000899243-18-014717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000089924318014717/doc4.xml","form_type":"4"}},{"id":3911538,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-06-01T21:43:57.000Z","date":"2018-05-30","kind":"sale","acquired":false,"shares":90000,"price":38,"value":3420000.0,"ownership":{"direct":true},"balance_after":332175,"source":{"system":"sec-edgar","filing":"0000899243-18-014717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000089924318014717/doc4.xml","form_type":"4"}},{"id":3911537,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2018-06-01T21:43:57.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":90000,"price":22.93,"value":2063700.0,"ownership":{"direct":true},"balance_after":422175,"source":{"system":"sec-edgar","filing":"0000899243-18-014717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000089924318014717/doc4.xml","form_type":"4"}},{"id":4196100,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2017-10-03T20:43:53.000Z","date":"2017-09-30","kind":"disposition_to_issuer","acquired":false,"shares":9238,"price":36.18,"value":334230.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":332175,"source":{"system":"sec-edgar","filing":"0001352413-17-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241317000006/edgardoc.xml","form_type":"4"}},{"id":4196099,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2017-10-03T20:43:53.000Z","date":"2017-09-30","kind":"disposition_to_issuer","acquired":false,"shares":19367,"price":36.18,"value":700698.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":341413,"source":{"system":"sec-edgar","filing":"0001352413-17-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241317000006/edgardoc.xml","form_type":"4"}},{"id":4206447,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2017-09-19T21:20:00.000Z","date":"2017-09-17","kind":"disposition_to_issuer","acquired":false,"shares":11671,"price":33.05,"value":385726.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":360780,"source":{"system":"sec-edgar","filing":"0001352413-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241317000004/edgardoc.xml","form_type":"4"}},{"id":4208749,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2017-09-15T20:31:54.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan.  Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements.  On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements.  Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020."}],"balance_after":372451,"source":{"system":"sec-edgar","filing":"0001352413-17-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241317000002/edgardoc.xml","form_type":"4"}},{"id":4590903,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2016-10-03T21:45:18.000Z","date":"2016-09-30","kind":"disposition_to_issuer","acquired":false,"shares":9238,"price":20.58,"value":190118.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":207451,"source":{"system":"sec-edgar","filing":"0001352413-16-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241316000012/edgardoc.xml","form_type":"4"}},{"id":4599365,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2016-09-20T12:16:31.000Z","date":"2016-09-17","kind":"disposition_to_issuer","acquired":false,"shares":8042,"price":20.92,"value":168238.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":216689,"source":{"system":"sec-edgar","filing":"0001352413-16-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241316000010/edgardoc.xml","form_type":"4"}},{"id":4601990,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23136,"kind":"person","name":"Capone Mark Christopher","position":1,"cik":"0001352413","reported_name":"Capone Mark Christopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & C.E.O."}}],"security":"Common Stock","published_at":"2016-09-16T17:30:55.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":78705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan.  Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2016, 25% on September 30, 2017, 25% on September 30, 2018, and 25% on September 30, 2019."}],"balance_after":224731,"source":{"system":"sec-edgar","filing":"0001352413-16-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000135241316000008/edgardoc.xml","form_type":"4"}}]}